IT1212658B - Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale - Google Patents
Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumoraleInfo
- Publication number
- IT1212658B IT1212658B IT8267487A IT6748782A IT1212658B IT 1212658 B IT1212658 B IT 1212658B IT 8267487 A IT8267487 A IT 8267487A IT 6748782 A IT6748782 A IT 6748782A IT 1212658 B IT1212658 B IT 1212658B
- Authority
- IT
- Italy
- Prior art keywords
- protein
- soln
- crude
- mol
- gel filtration
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 230000003013 cytotoxicity Effects 0.000 title 1
- 231100000135 cytotoxicity Toxicity 0.000 title 1
- 238000002523 gelfiltration Methods 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229920002301 cellulose acetate Polymers 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000001962 electrophoresis Methods 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8267487A IT1212658B (it) | 1982-04-13 | 1982-04-13 | Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8267487A IT1212658B (it) | 1982-04-13 | 1982-04-13 | Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8267487A0 IT8267487A0 (it) | 1982-04-13 |
| IT1212658B true IT1212658B (it) | 1989-11-30 |
Family
ID=11302821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT8267487A IT1212658B (it) | 1982-04-13 | 1982-04-13 | Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1212658B (it) |
-
1982
- 1982-04-13 IT IT8267487A patent/IT1212658B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| IT8267487A0 (it) | 1982-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK382986D0 (da) | Aktivering af makrofag tumoricid aktivitet med granulocytmakrofag kolonistimulationsfaktor | |
| ATE63748T1 (de) | Enzymwiderstandsfaehige immunomodulatorische peptide. | |
| GB1356911A (en) | Purification and fractionation of carcinoembryonic antigen | |
| EP0911033A3 (en) | Methods and compositions for the treatment of diseases with interferon while reducing side effects | |
| ATA84882A (de) | Therapeutisches abgabesystem zur verabreichung eines wirkstoffes durch die haut | |
| IT8709354A0 (it) | Siringa per iniezioni,in specie endovenose,realizzata per poteressere usata una sola volta,senza possibilita' di riaspirazione. | |
| GB9224584D0 (en) | Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases | |
| EP0218531A3 (en) | Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies | |
| NZ209590A (en) | Gamma interferon analogue, preparation and pharmaceutical composition | |
| AU3683484A (en) | The use of menthol to enhance transdermal drug delivery | |
| HK1006154A1 (en) | Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis | |
| IL77101A (en) | Method for purifying a human tnf produced by recombinant dna technique | |
| JPS57140725A (en) | Physiologically active substance having carcinostatic action | |
| ES2148526T3 (es) | Formulaciones liquidas de ifn-beta. | |
| AU2855189A (en) | Method of treating fibrotic disorders | |
| PL295273A1 (en) | Method of obtaining a preparation capable to retard the synthesis of endogenous cytotoxic cytokinins | |
| IT1212658B (it) | Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale | |
| DE3863200D1 (de) | In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen. | |
| EP0273778A3 (en) | Synergistic behavior of csf-1 and g-csf | |
| AU7336687A (en) | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon | |
| PT80214B (en) | Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon | |
| CA2004202A1 (en) | Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon | |
| EP0219839A3 (de) | Derivat des Interleukin-2, seine Herstellung und Verwendung | |
| Meisel et al. | Efficacy of ciprofloxacin in bacterial infections of the skin. | |
| RU96102282A (ru) | Способ терапии поллиноза |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970429 |